ASBP
Price
$0.28
Change
-$0.03 (-9.68%)
Updated
Jun 27 closing price
Capitalization
N/A
BRNS
Price
$0.92
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
36.95M
39 days until earnings call
Interact to see
Advertisement

ASBP vs BRNS

Header iconASBP vs BRNS Comparison
Open Charts ASBP vs BRNSBanner chart's image
Aspire Biopharma Holdings
Price$0.28
Change-$0.03 (-9.68%)
Volume$3.64M
CapitalizationN/A
Barinthus Biotherapeutics
Price$0.92
Change-$0.00 (-0.00%)
Volume$2.91K
Capitalization36.95M
ASBP vs BRNS Comparison Chart in %
Loading...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. BRNS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Hold and BRNS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ASBP: $0.28 vs. BRNS: $0.92)
Brand notoriety: ASBP and BRNS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 69% vs. BRNS: 8%
Market capitalization -- ASBP: $0 vs. BRNS: $36.95M
ASBP [@Biotechnology] is valued at $0. BRNS’s [@Biotechnology] market capitalization is $36.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileBRNS’s FA Score has 1 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • BRNS’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 2 TA indicator(s) are bullish while BRNS’s TA Score has 3 bullish TA indicator(s).

  • ASBP’s TA Score: 2 bullish, 6 bearish.
  • BRNS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ASBP is a better buy in the short-term than BRNS.

Price Growth

ASBP (@Biotechnology) experienced а -1.90% price change this week, while BRNS (@Biotechnology) price change was +9.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS YTD gains are higher at: -23.634 vs. ASBP (-97.526).
ASBPBRNSASBP / BRNS
CapitalizationN/A37M-
EBITDAN/A-58.89M-
Gain YTD-97.526-23.634413%
P/E RatioN/AN/A-
RevenueN/A15M-
Total CashN/A99.1M-
Total DebtN/A11.9M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPBRNS
RSI
ODDS (%)
Bearish Trend 3 days ago
16%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
33%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
23%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
17%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
32%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
34%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY614.913.04
+0.50%
SPDR® S&P 500® ETF
BTC.X107327.700000239.273440
+0.22%
Bitcoin cryptocurrency
AAPL201.00N/A
N/A
Apple
TSLA323.63-2.15
-0.66%
Tesla
GME23.59-0.29
-1.21%
GameStop Corp

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-7.03%
SPRO - ASBP
62%
Loosely correlated
+1.38%
ALZN - ASBP
28%
Poorly correlated
-0.68%
BRNS - ASBP
28%
Poorly correlated
N/A
ORIC - ASBP
27%
Poorly correlated
-1.81%
BLUE - ASBP
27%
Poorly correlated
N/A
More

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with NGNE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
N/A
NGNE - BRNS
51%
Loosely correlated
-2.47%
NRIX - BRNS
32%
Poorly correlated
+0.17%
ASBP - BRNS
26%
Poorly correlated
-7.03%
CRNX - BRNS
25%
Poorly correlated
-0.10%
SLN - BRNS
25%
Poorly correlated
+4.51%
More